Forward Looking Statements



This Quarterly Report and certain information incorporated herein by reference
contain forward-looking statements and information within the "safe harbor"
provisions of the Private Securities Litigation Reform Act of 1995, Section 27A
of the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"). This information includes
assumptions made by, and information currently available to management,
including statements regarding future economic performance and financial
condition, liquidity and capital resources, and management's plans and
objectives. In addition, certain statements included in this Quarterly Report,
in the Company's future filings with the SEC, in press releases, and in oral and
written statements made by us or with our approval, which are not statements of
historical fact, are forward-looking statements. Words such as "may," "could,"
"should," "would," "believe," "expect," "anticipate," "estimate," "intend,"
"seek," "plan," "project," "continue," "predict," "will," and other words or
expressions of similar meaning are intended by us to identify forward-looking
statements, although not all forward-looking statements contain these
identifying words. Forward-looking statements are based on the Company's current
expectations about future events or results and information that is currently
available to us, involve assumptions, risks, and uncertainties, and speak only
as of the date on which such statements are made.

All forward-looking statements are subject to the risks and uncertainties
inherent in predicting the future. The Company's actual results may differ
materially from those projected, stated or implied in these forward-looking
statements as a result of many factors, including the Company's critical
accounting policies and risks and uncertainties related to, but not limited to,
the operating results of the Company's tenants, the overall industry
environment, the Company's financial condition, and the impact of the COVID-19
pandemic on the Company's business. These and other risks and uncertainties are
described in more detail in the Annual Report and in Part II, Item 1A of this
Quarterly Report, as well as other reports that the Company files with the SEC.

Forward-looking statements speak only as of the date they are made and should
not be relied upon as representing the Company's views as of any subsequent
date. The Company undertakes no obligation to update or revise such statements
to reflect new circumstances or unanticipated events as they occur, except as
required by applicable laws, and you are urged to review and consider
disclosures that the Company makes in this Quarterly Report and other reports
that the Company files with the SEC that discuss factors germane to the
Company's business.

Overview

Regional Health, through its subsidiaries, is a self-managed real estate
investment company that invests primarily in real estate purposed for long-term
care and senior living. Our business primarily consists of leasing and
subleasing healthcare facilities to third-party tenants. As of September 30,
2021, the Company owned, leased or managed for third parties, or operated, 24
facilities, primarily in the Southeastern United States. Of the 24 facilities,
the Company: (i) leased 10 skilled nursing facilities (which the Company owns)
to third-party tenants, subleased eight skilled nursing facilities (which the
Company leases) to third-party tenants, and operated, as of January 1, 2021 as a
portfolio stabilization measure, one previously subleased skilled nursing
facility (which the Company leases); (ii) leased two assisted living facilities
(which the Company owns) to third-party tenants; and (iii) managed, on behalf of
third-party owners, two skilled nursing facilities and one independent living
facility. Accordingly, as of January 1, 2021, the Company has two primary
reporting segments, Real Estate Services and Healthcare Services.

Effective January 1, 2021, pursuant to the Wellington Lease Termination for two
SNFs located in Georgia with affiliates of Wellington, the Company, as a
portfolio stabilization measure, commenced operating the previously subleased
Tara Facility and entered into a new sublease agreement with an affiliate of
Empire for the Powder Springs Facility. The Company had entered into the Vero
Management Agreement with Vero Health under which Vero Health provided
management consulting services for the Tara Facility, which the Company now
operates. On September 21, 2021, the Company notified Vero Health of Regional's
intention to terminate the Vero Management Agreement, effective October 1, 2021.
Regional will continue to operate the Tara Facility and has entered into the
Peach Management Agreement with Peach, dated as of September 22, 2021 and
effective October 1, 2021, to provide management consulting services for the
Tara Facility. Affiliates of Peach also lease from Regional three facilities
located in Georgia. The fixed Management fee Regional will pay Peach is 1% less
than under the Vero Management Agreement, with additional percentages for
meeting specified performance targets. See Note 6 - Leases located in Part I,
Item 1, "Financial Statements", of this Quarterly Report, and Note 6 - Leases in
Part II, Item 8, "Financial Statements and Supplemental Data" in the Company's
Annual Report, for a more detailed description of the Company's leases.

The operators of the Company's facilities provide a range of health care and
related services to patients and residents, including skilled nursing and
assisted living services, social services, various therapy services, and other
rehabilitative and healthcare services for both long-term and short-stay
patients and residents.

                                       33

--------------------------------------------------------------------------------

Risks and Uncertainties



While the Company is a self-managed real estate investment company that invests
primarily in real estate purposed for long-term care and senior living, the
Company, when business conditions require, may undertake portfolio stabilization
measures, such as operating a previously leased facility. On January 1, 2021,
following the Wellington Transition, the Company commenced operating the Tara
Facility, which facility comprises approximately 5.0% of the total amount of the
Company's licensed patient beds. This portfolio stabilization measure exposes
the Company directly to all the risks our tenants face as discussed in this
"Risk and Uncertainties" section.

On March 11, 2020, the World Health Organization declared the outbreak of the
respiratory illness caused by a novel strain of coronavirus, SARS-CoV-2, also
known as COVID-19, a global pandemic. The COVID-19 pandemic has led governments
and other authorities in the United States to impose measures intended to
control its spread, including restrictions on freedom of movement and business
operations such as travel bans, border closings, business closures, quarantines
and shelter-in-place orders. The COVID-19 pandemic and the measures to protect
its spread have adversely affected our business during the nine months ended
September 30, 2021, and we expect it will continue to adversely affect our
business in the quarter ending December 31, 2021 and beyond, for a variety of
reasons, including those discussed below and elsewhere in this Quarterly Report.

As of October 29, 2021, the Company is aware that each of our facilities has
reported one or more positive cases of COVID-19 among the residents and/or
operator employee populations. Many of our operators have reported incurring
significant cost increases as a result of the COVID-19 pandemic, with dramatic
increases for facilities with positive cases. We believe these increases
primarily stem from elevated labor costs, including increased use of overtime
and bonus pay, as well as a significant increase in both the cost and usage of
personal protective equipment, testing equipment, processes and supplies. In
terms of occupancy levels, many of our operators have reported experiencing
declines, in part due to the elimination or suspension of elective hospital
procedures, fewer discharges from hospitals to SNFs, and higher hospital
re-admittances from SNFs.

The COVID-19 pandemic may also lead to temporary closures of nursing facilities,
operated by our tenants, which also may affect our tenants' ability to make
their rental payments to us pursuant to their respective lease agreements. In
addition, our tenants' operations could be further disrupted if any of their
employees, or the employees of their vendors, have, or are suspected of having,
COVID-19. This could cause, and in some cases has already caused, our tenants or
their vendors to experience staffing shortages, and this could potentially
require our tenants and their vendors to close parts of or entire facilities,
distribution centers, or other buildings to disinfect any affected areas.

We could also be adversely affected if government authorities impose upon our
tenants, or their vendors, certain restrictions due to the COVID-19 pandemic.
These restrictions may be in the form of mandatory closures, requested voluntary
closures, bans on new admissions, restricted operations, or restrictions on the
importation of necessary equipment or supplies which may adversely affect our
tenants' operations and their ability to make rental payments to us moving
forward. In addition, family members may elect to keep nursing facility
residents at home during the COVID-19 pandemic, thus reducing our tenants'
revenue. Currently, a number of our tenants have stopped admitting new patients
due to rising COVID-19 infections which has resulted in decreased revenues.

As a result of the COVID-19 pandemic, our tenants may face lawsuits for alleged
negligence associated with their responses to the emergency. The costs
associated with defending, settling, or paying damages from such claims could
negatively impact our tenants' operating budgets and affect their ability to
meet their obligations under our leases. Further, we may be subject to increased
lawsuits arising out of our alleged actions or the alleged actions of our
tenants for which they have agreed to indemnify, defend and hold us harmless. An
unfavorable resolution of any such pending or future litigation could materially
adversely affect us. The Company is not aware of any such lawsuits against our
tenants.

If our tenants are unable to make rental payments to us pursuant to their lease
obligations, whether due to the tenants' decrease in revenues or otherwise,
then, in some cases, we may be forced to either attempt to replace the tenants
or restructure the tenants' long-term rent obligations and may not be able to do
so on terms that are as favorable to us as those currently in place.

While the Company has received approximately 97% of its anticipated fixed
monthly rental receipts from tenants for the three and nine months ended
September 30, 2021, there are a number of uncertainties the Company faces as it
considers the potential impact of COVID-19 on its business, including the length
of census disruption, elevated COVID-19 operating costs related to personal
protection equipment, cleaning supplies, virus testing and increased overtime
due to staff illness.



On November 5, 2021, the CMS published COVID-19 Health Care Staff Vaccination
requirements that most Medicare- and Medicaid-certified providers and suppliers
must meet in order to participate in the Medicare and Medicaid programs. This
emergency regulation was effective immediately and requires employees at
Medicare and Medicaid-participating facilities and

                                       34

--------------------------------------------------------------------------------


employers with more than 100 employees to be vaccinated. Some states have also
issued their own orders to employers and healthcare providers that may or may
not align with federal directives. The legality of both federal and state
vaccine mandates will likely be decided by the courts. Until pending laws and
regulations related to vaccine mandates are both finalized and adjudicated, our
tenants will continue to manage in different ways, from mandating vaccines for
all employees to waiting to see how the issue is ultimately resolved. The
mandates, as presently written, may cause disruption to tenants' operations if
employees refuse vaccination and are terminated, and our tenants are not able to
replace them in a timely manner or experience increased costs to do so.



To help offset these costs as well as occupancy declines, various relief
programs have been enacted by federal and state governments, which have
provided, and we expect will continue to provide, some payments to our tenants,
subject to the programs' respective terms and conditions. The CARES Act
established a grant program administered by the HHS under which Provider Relief
Funds have been made available. In early November 2021, the HHS closed the
application portal for its Phase 4 allocation of approximately $17 billion of
Provider Relief Funds and an allocation of approximately $8.5 billion in
American Rescue Plan resources for providers serving patients living in rural
areas. We expect that our tenants pursued additional funding from these
allocations, and will pursue any future funding that may become available,
though there can be no assurance that our tenants will qualify for, or receive,
any Phase 4 or American Rescue Plan, or any future, funding.

We also do not know the number of facilities that will ultimately experience
widespread, high-cost outbreaks of COVID-19. While we have requested reporting
case numbers from our operators and CMS has required additional reporting by
operators, we may not receive accurate information on the number of cases, which
could result in a delay in reporting. We expect to see continued increased
clinical protocols for infection control within facilities and increased
monitoring of employees, guests and other individuals entering facilities;
however, we do not yet know if future reimbursement rates in combination with
the various relief programs that have been made available will be sufficient to
cover the increased costs of enhanced infection control and monitoring. The
extent of the COVID-19 pandemic's effect on our and our operators' operational
and financial performance will depend on future developments, including the
ultimate duration, spread and intensity of the outbreak, which may depend on
factors such as the development and implementation of an effective vaccine and
treatments for COVID-19, government funds and other support for the senior care
sector and the efficacy of other policies and measures that may mitigate the
impact of the pandemic, all of which are uncertain and difficult to predict. Due
to these uncertainties, we are unable at this time to estimate the effect of
these factors on our business, but the adverse impact on our business, results
of operations, financial condition and cash flows could be material.


                                       35

--------------------------------------------------------------------------------





Portfolio

The following table provides summary information regarding the number of facilities and related licensed beds/units as of September 30, 2021:





                                                                                                                                              Managed for Third
                                       Owned                            Leased                         Leased Operating                            Parties                               Total
                            Facilities       Beds/Units       Facilities       Beds/Units        Facilities          Beds/Units       Facilities            Beds/Units        Facilities       Beds/Units
State
Alabama                               2              230                -                -                  -                  -                -                      -                2              230
Georgia                               3              395                7              750                  1                134                -                      -               11            1,279
North Carolina                        1              106                -                -                  -                  -                -                      -                1              106
Ohio                                  4              291                1               99                  -                  -                3                    332                8              722
South Carolina                        2              180                -                -                  -                  -                -                      -                2              180
Total                                12            1,202                8              849                  1                134                3                    332               24            2,517
Facility Type
Skilled Nursing                      10            1,016                8              849                  1                134                2                    249               21            2,248
Assisted Living                       2              186                -                -                  -                  -                -                      -                2              186
Independent Living                    -                -                -                -                  -                  -                1                     83                1               83
Total                                12            1,202                8              849                  1                134                3                    332               24            2,517




The following table provides summary information regarding the number of
facilities and related licensed beds/units by operator affiliation as of
September 30 2021:



                                  Number of
Operator Affiliation            Facilities (1)      Beds / Units
C.R. Management                               6               689
Aspire                                        5               390
Peach Health Group                            3               266
Symmetry Healthcare                           2               180
Beacon Health Management                      2               212
Vero Health Management                        1               106
Empire (2)                                    1               208
Subtotal                                     20             2,051
Regional Health Managed                       3               332
Regional Health Operated (3)                  1               134
Total                                        24             2,517



(1) Represents the number of facilities leased or subleased to separate tenants,

of which each tenant is an affiliate of the entity named in the table above.

For a more detailed discussion, see Note 6 - Leases located in Part I, Item

1, "Financial Statements", of this Quarterly Report; Note 6 - Leases in Part

II, Item 8, "Financial Statements and Supplementary Data", included in the

Annual Report; and "Portfolio of Healthcare Investments" included in Part I,

Item 1, "Business" included in the Annual Report.

(2) Effective January 1, 2021, the Company entered into the PS Sublease with an

affiliate of Empire for the Powder Springs Facility. See Note 6 - Leases in

Part I, Item 1, "Financial Statements (unaudited)" in this Quarterly Report.

(3) Effective January 1, 2021, Regional began operating the Tara Facility and

entered into the Vero Management Agreement with Vero Health under which Vero

Health provided management consulting services for the Tara Facility. On

September 21, 2021, the Company notified Vero Health of Regional's intention

to terminate the Vero Management Agreement, effective October 1, 2021.

Regional will continue to operate the Tara Facility and has entered into the

Peach Management Agreement with Peach, dated as of September 22, 2021 and

effective October 1, 2021, to provide management consulting services for the


    Tara Facility.




                                       36

--------------------------------------------------------------------------------





Portfolio Occupancy Rates

The following table provides summary information regarding our portfolio facility-level occupancy rates for the periods shown:





                                         For the Twelve Months Ended
                       December 31,       March 31,       June 30,       September 30,
Operating Metric (1)       2020             2021            2021             2021
Occupancy (%)                   67.3 %          68.6 %         67.7 %              66.7 %



(1) Excludes three managed facilities in Ohio.

Lease Expiration

The following table provides summary information regarding our lease expirations for the years shown as of September 30, 2021:





                                    Licensed Beds               Annual Lease Revenue (1)
              Number of                                        Amount
              Facilities      Amount       Percent (%)         '000's           Percent (%)
2023                    1          62               3.0 %   $         263                1.9 %
2024                    1         126               6.1 %             965                6.8 %
2025                    2         269              13.1 %           2,219               15.6 %
2026                    -           -               0.0 %               -                0.0 %
2027                    7         750              36.6 %           5,241               36.9 %
2028                    4         328              16.0 %           2,352               16.6 %
2029                    1         106               5.2 %             538                3.8 %
Thereafter              4         410              20.0 %           2,603               18.4 %
Total                  20       2,051             100.0 %   $      14,181              100.0 %




(1) Straight-line rent.

Acquisitions and Divestitures

There were no acquisitions or divestitures during the three and nine months ended September 30, 2021 or September 30, 2020.

For historical information regarding the Company's acquisitions and divestitures, see Note 9 - Acquisitions and Dispositions and Note 10 - Discontinued Operations Part II, Item 8, "Financial Statements and Supplementary Data", included in the Annual Report.

Critical Accounting Policies



We prepare our financial statements in accordance with GAAP for interim
financial information and with the instructions to Form 10-Q and Rule 8-03 of
Article 8 of Regulation S-X. The preparation of these financial statements
requires us to make estimates and judgments that affect the reported amount of
assets, liabilities, revenues and expenses. On an ongoing basis, we review our
judgments and estimates, including, but not limited to, those related to
doubtful accounts, income taxes, stock compensation, intangible assets and loss
contingencies. We base our estimates on historical experience, business
knowledge and on various other assumptions that we believe to be reasonable
under the circumstances at the time. Actual results may vary from our estimates.
These estimates are evaluated by management and revised as circumstances change.

For a discussion of our critical accounting policies, see Note 1 - Organization
and Significant Accounting Policies to the Company's Notes to our consolidated
financial statements located in Part I, Item 1, "Financial Statements
(unaudited)", of this Quarterly Report.

                                       37

--------------------------------------------------------------------------------

Results of Operations



The following table sets forth, for the periods indicated, an unaudited
statement of operations items and the amounts and percentages of change of these
items. The results of operations for any particular period are not necessarily
indicative of results for any future period. The following data should be read
in conjunction with our consolidated financial statements and the notes thereto,
which are included herein.



                                        Three Months Ended September 30,                   Nine Months Ended September 30,
                                                                     Percent                                           Percent
(Amounts in 000's)                   2021             2020          Change (*)          2021             2020         Change (*)
Revenues:
Patient care revenues             $    2,309       $        -                NM      $     7,444       $       -               NM
Rental revenues                        4,136            4,308              (4.0 )%        11,980          12,898             (7.1 )%
Management fees                          248              244               1.6 %            743             732              1.5 %
Other revenues                             9              215             (95.8 )%            84             224            (62.5 )%
Total revenues                         6,702            4,767              40.6 %         20,251          13,854             46.2 %
Expenses:
Patient care expense                   2,454                -                NM            6,911               -               NM
Facility rent expense                  1,640            1,640               0.0 %          4,919           4,919              0.0 %
Cost of management fees                  153              161              (5.0 )%           468             486             (3.7 )%
Depreciation and amortization            651              694              (6.2 )%         1,953           2,239            (12.8 )%
General and administrative
expenses                                 972              743              30.8 %          2,953           2,334             26.5 %
Doubtful accounts expense                  -              790            (100.0 )%            77             653            (88.2 )%
Other operating expenses                 204              109              87.2 %            679             630              7.8 %
Total expenses                         6,074            4,137              46.8 %         17,960          11,261             59.5 %
Income from operations                   628              630              (0.3 )%         2,291           2,593            (11.6 )%
Other expense (income) :
Interest expense, net                    669              692              (3.3 )%         2,022           2,091             (3.3 )%
Gain on extinguishment of debt          (146 )              -                NM             (146 )             -               NM
Other expense, net                       122                9                NM              839             144               NM
Total other expense, net                 645              701              (8.0 )%         2,715           2,235             21.5 %
(Loss) income from continuing
operations before income taxes           (17 )            (71 )           (76.1 )%          (424 )           358           (218.4 )%
(Loss) income from continuing
operations                               (17 )            (71 )           (76.1 )%          (424 )           358           (218.4 )%
Loss from discontinued
operations, net of tax                   (22 )             (2 )              NM              (97 )           (33 )          193.9 %
Net loss                          $      (39 )     $      (73 )           (46.6 )%   $      (521 )     $     325           (260.3 )%




* Not meaningful ("NM").



Three Months Ended September 30, 2021 and 2020

Patient care revenues-Patient care revenues for our new Healthcare Services segment, as a result of the Company operating the Tara Facility, were $2.3 million for the three months ended September 30, 2021, which due to lower occupancy in the current year, is approximately 21.5% less than the prior year financials we received from the prior Wellington affiliated operator.


                                       38

--------------------------------------------------------------------------------


Rental revenues-Rental revenue for our Real Estate Services segment decreased by
approximately $0.2 million, or 4.0%, to $4.1 million for the three months ended
September 30, 2021, compared with $4.3 million for the same period in 2020. The
decrease reflects an approximately $0.9 million decrease in straight-line rent
due to the Wellington Lease Termination, approximately $0.5 million and $0.4
million recognized for the three months ended September 30, 2020 for the Powder
Springs Facility and the Tara Facility, respectively, partially offset by
approximately $0.2 million straight-line rent and approximately $0.5 million
variable rent recognized from the Powder Springs Facility under a new sublease
with an affiliate of Empire in the current period. For further information see
Note 6 - Leases to our consolidated financial statements in Part I, Item 1,
"Financial Statements (unaudited)" in this Quarterly Report.

Other revenues-Other revenues for our Real Estate Services segment decreased by
approximately $0.2 million for the three months ended September 30, 2021,
compared to the same period in 2020. This decrease is due to the previously
deferred interest earned on the Peach Line pursuant to the Peach Line
modification in the prior year quarter and the Peach Health Sublessees repaying
its third-party Peach Working Capital Facility, to which the Peach Line was
subordinated

Patient care expense-Patient care expense was $2.5 million for the three months
ended September 30, 2021. The current period expense, which required an
increased utilization of agency staffing, is due to the costs of operating the
Tara Facility in our new Healthcare Services reporting segment.



                                            Three Months Ended September 30,
                                                                         Percent
(Amounts in 000's)                       2021            2020          Change (*)
General and administrative expenses:
Real Estate Services                   $     861       $     743              15.9 %
Healthcare Services                          111               -                NM
Total                                  $     972       $     743              30.8 %




* Not meaningful ("NM").


General and administrative expenses- General and administrative expenses
increased by approximately $0.3 million, or 30.8%, to $1.0 million for the three
months ended September 30, 2021, compared with $0.7 million for the same period
in 2020. The increase is driven by $0.2 million of non-cash stock compensation
for the issuance of restricted share awards for employees and executive officers
and $0.1 million incurred per the Vero Management Agreement, in our Healthcare
Services segment, which provides remuneration to Vero of 5.0% of our Patient
care revenues (net of contractual allowances) to provide management consulting
services for the Tara Facility.

Doubtful accounts expense- The current period expense is due to approximately
$0.1 million provision for doubtful accounts in our Healthcare Services segment
partially offset by approximately $0.1 million of Wellington rent receivable
cash collections in excess of our prior year provision for non-payment of rent
in our Real Estate Services segment. The prior period expense is related to the
provision for non-payment of rent by Wellington.

Other operating expenses - Other operating expenses increased by approximately
$0.1 million or 87.2%, to $0.2 million for the three months ended September 30,
2021, compared with $0.1 million for the same period in 2020. The increase is
due to the reversal of a provision for bed taxes related to the Peach Line
modification in the prior year quarter.

Gain on extinguishment of debt- Gain on extinguishment of debt is due to the PPP Loan debt forgiveness of $0.2 million partially offset by $0.1 million of deferred financing fees from the extinguishment of the Coosa MCB Loan.

Other expense (income), net- Other expense (income), net increased by approximately $0.1 million, to $0.1 million, for the three months ended September 30, 2021. These expenses are related to professional and legal services to evaluate and assist with possible opportunities to improve the Company's capital structure.

Nine Months Ended September 30, 2021 and 2020

Patient care revenues-Patient care revenues for our new Healthcare Services segment, as a result of the Company operating the Tara Facility, were $7.4 million for the nine months ended September 30, 2021, which due to lower occupancy in the current year, is approximately 15.1% less than the prior year financials we received from the prior Wellington affiliated operator.



Rental revenues-Rental revenue for our Real Estate Services segment, decreased
by approximately $0.9 million, or 7.1%, to $12.0 million for the nine months
ended September 30, 2021, compared with $12.9 million for the same period in
2020. The decrease reflects approximately $2.8 million decrease in straight-line
rent due to the Wellington Lease Termination, $1.5

                                       39

--------------------------------------------------------------------------------


million and $1.3 million recognized for the nine months ended September 30, 2020
for the Powder Springs Facility and the Tara Facility respectively, partially
offset by $0.9 million straight-line rent and approximately $1.0 million
variable rent recognized from the Powder Springs Facility under a new sublease
with an affiliate of Empire in the current period. For further information see
Note 6 - Leases to our consolidated financial statements in Part I, Item 1,
"Financial Statements (unaudited)" in this Quarterly Report.

Other revenues-Other revenue for our Real Estate Services segment decreased by
approximately $0.1 million, for the nine months ended September 30, 2021,
compared to the same period in 2020. This decrease is due to recognition of the
Symmetry Payment Plan fees and interest earned on the Peach Line, which had
previously been deferred due to the Peach Line's subordination to the Peach
Health Sublessees third-party Peach Working Capital Facility until its repayment
in the prior year.

Patient care expense-Patient care expense was $6.9 million for the nine months ended September 30, 2021. The current year expense is due to the costs of operating the Tara Facility in our new Healthcare Services reporting segment.



Depreciation and amortization-Depreciation and amortization for our Real Estate
Services segment decreased by approximately $0.2 million, or 12.8%, to $2.0
million for the nine months ended September 30, 2021, compared with $2.2 million
for the same period in 2020. This decrease is mainly due to the full
depreciation of certain building improvements and equipment and computer related
assets.



                                              Nine Months Ended September 30,
                                                                           Percent
(Amounts in 000's)                        2021              2020         Change (*)
General and administrative expenses:
Real Estate Services                   $     2,583       $     2,334            10.7 %
Healthcare Services                            370                 -              NM
Total                                  $     2,953       $     2,334            26.5 %




* Not meaningful ("NM").


General and administrative expenses- General and administrative expenses
increased by approximately $0.7 million, or 26.5%, to $3.0 million for the nine
months ended September 30, 2021, compared with $2.3 million for the same period
in 2020. The increase is driven by $0.3 million of non-cash stock compensation
for the issuance of restricted share awards for employees and approximately $0.4
million incurred per the Vero Management Agreement, in our Healthcare Services
segment, which provides remuneration to Vero of 5.0% of our Patient care
revenues (net of contractual allowances) to provide management consulting
services for the Tara Facility.

Doubtful accounts expense- The current period expense is due to a $0.2 million
provision for doubtful accounts in our Healthcare Services segment partially
offset by approximately $0.1 million of Wellington rent receivable cash
collections in excess of our prior year provision for non-payment of rent in our
Real Estate Services segment. The prior period expense is related to a $0.9
million provision of outstanding rent arrears from Wellington, offset by $0.2
million related to the collection of amounts owed to the Company under tenant
payment plans previously not considered collectible.

Other operating expenses - Other operating expenses increased by approximately
$0.1 million or 7.8%, to $0.7 million for the nine months ended September 30,
2021, compared with $0.6 million for the same period in 2020. The increase is
due to the reversal of a provision for bed taxes related to the Peach Line
modification in the prior year quarter.

Gain on extinguishment of debt- Gain on extinguishment of debt is due to the PPP Loan debt forgiveness of $0.2 million partially offset by $0.1 million of deferred financing fees from the extinguishment of the Coosa MCB Loan.



Other expense, net- Other expense, net increased by approximately $0.7 million,
to $0.8 million, for the nine months ended September 30, 2021, compared with
$0.1 million for the same period in 2020. These expenses in both years are
related to professional and legal services to evaluate and assist with possible
opportunities to improve the Company's capital structure.

For further information on the Tara Facility performance, see Note 13 - Segment
Results to the Company's consolidated financial statements located in Part I,
Item 1, Notes to Consolidated Financial Statements", of this Quarterly Report.

Liquidity and Capital Resources

Overview



The Company intends to pursue measures to grow its operations, streamline its
cost infrastructure and otherwise increase liquidity, including: (i) refinancing
or repaying debt to reduce interest costs and mandatory principal repayments,
with such

                                       40

--------------------------------------------------------------------------------


repayment to be funded through potentially expanding borrowing arrangements with
certain lenders; (ii) increasing future lease revenue through acquisitions and
investments in existing properties; (iii) modifying the terms of existing
leases; (iv) replacing certain tenants who default on their lease payment terms;
and (v) reducing other and general and administrative expenses.

Management anticipates access to several sources of liquidity, including cash on
hand, cash flows from operations, and debt refinancing during the twelve months
following the date of this filing. At September 30, 2021, the Company had $6.2
million in unrestricted cash, including a Medicaid overpayment of $1.0 million
received on September 30, 2021, which the Company expects to repay in the near
future and is recorded in "Accrued Expenses" in the Company's consolidated
balance sheets as of September 30, 2021. During the nine months ended September
30, 2021, the Company generated positive cash flow from continuing operations of
$4.3 million and anticipates continued positive cash flow from operations in the
future, subject to the continued uncertainty of the COVID-19 pandemic and its
impact on the Company's business, financial condition and results of operations.

As of December 31, 2020, Regional recorded an estimated allowance of $1.4
million against a rent receivable of $2.7 million from the Wellington Tenants.
During the three months ended September 2021, the Company recorded $0.1 million
in debt recovery due to collections exceeding our December 31, 2020 estimated
allowance. During the nine months ended September 30, 2021, the Company
collected $3.3 million pursuant to the Wellington Lease Termination (excluding
$0.2 million insurance refund) and paid $1.0 million to partially satisfy the
Wellington Lease Termination obligation of approximately of $1.7 million of bed
taxes in arrears and $0.1 million in collection expenses. The Company provides
no assurance that we will be able to collect any of the additional $1.2 million
in rent arrears in excess of the net $1.5 million already collected.

During the three and nine months ended September 30, 2021, the Company
recognized approximately $0.5 million and $1.0 million respectively, of variable
rent for the Powder Springs Facility and, as of the date of filing this
Quarterly Report, has collected all of such variable rent replacing
approximately $1.5 million of cash rent previously anticipated from the
Wellington Tenant. The Tara Facility operations performance during the three and
nine months ended September 30, 2021 has been insufficient to cover any of the
rent the Company is obligated to pay under its lease. On January 1, 2021, the
Company had entered into the Vero Management Agreement with Vero Health under
which Vero Health provided management consulting services for the Tara Facility,
which the Company now operates. On September 21, 2021, the Company notified Vero
Health, of Regional's intention to terminate the Vero Management Agreement,
effective October 1, 2021. Regional will continue to operate the Tara Facility
and has entered into the Peach Management Agreement with Peach dated as of
September 22, 2021 and effective October 1, 2021 to provide management
consulting services for the Tara Facility. Affiliates of Peach also lease from
Regional three facilities located in Georgia. The fixed Management fee Regional
will pay Peach is 1% less than under the Vero Management Agreement with
additional percentages for meeting specified performance targets. For further
information on the Peach Management Agreement see Note 8 - Leases and Note 13 -
Segment Results to the Company's consolidated financial statements located in
Part I, Item 1, Notes to Consolidated Financial Statements", of this Quarterly
Report.



Debt Extinguishment. On August 13, 2021, the Company received official
notification from FountainHead Commercial Capital, providers of our $0.2 million
Paycheck Protection Program Loan ("PPP Loan), that the full $0.2 million was
forgiven by the SBA on July 9, 2021.



As of September 30, 2021, the Company had $53.4 million in indebtedness, net of
$1.3 million deferred financing, and unamortized discounts. The Company
anticipates net principal repayments of approximately $2.0 million during the
next twelve-month period, approximately $1.3 million of routine debt service
amortization, $0.6 million of current maturities of other debt (including $0.1
million related to insurance financing for the Tara Facility operations), and a
$0.1 million payment of bond debt.

On September 30, 2021, the Company and the Exchange Bank of Alabama executed a
$5.1 million Promissory Note with a 3.95% annual fixed interest rate and
maturity date of October 10, 2026. The Coosa Credit Facility refinanced $5.1
million prime + 1.5% variable interest rate debt owed to Metro City Bank with a
maturity date of January 31, 2036. The Coosa Credit Facility is secured by the
assets of Coosa, which includes the Coosa Facility and the assets of Meadowood
which includes the Meadowood Facility. The Company incurred approximately $0.1
million in new deferred financing fees and expensed approximately $0.1 million
deferred financing fees associated with the Coosa MCB Loan.

Consequently the Company recorded a net gain of approximately $0.1 million on
extinguishment of debt during the three months ended September 30, 2021, being
$0.2 million gain on forgiveness of the PPP Loan partially offset by $0.1
million of expensed deferred financing fees associated with the extinguishment
of the Coosa MCB Loan.

Debt Modification. In conjunction with the September 30, 2021 Coosa Facility
refinance, the Company and the Exchange Bank of Alabama executed the Meadowood
Credit Facility that extended the maturity date on $3.5 million Meadowood Credit

                                       41

--------------------------------------------------------------------------------


Facility, as amended, in current senior debt secured by the assets of Coosa and
the assets of Meadowood, other mortgage indebtedness from May 1, 2022 to October
1, 2026. Additionally on August 17, 2021, the Company extended the maturity date
on approximately $0.5 million other debt from August 25, 2021 to August 25, 2023
(known as the "KeyBank Exit Notes").



Company recorded a net gain of approximately $0.1 million on extinguishment of
debt during the three months ended September 30, 2021, being $0.2 million gain
on forgiveness of the PPP Loan partially offset by $0.1 million of expensed
deferred financing fees associated with the extinguishment of the Coosa MCB
Loan.

For further information, see Note 8 - Notes Payable and Other Debt to the Company's consolidated financial statements located in Part I, Item 1, Notes to Consolidated Financial Statements", of this Quarterly Report.



The Company is current with all of its Notes payable and other debt as described
in Note 8 - Notes Payable and Other Debt, to the Company's Notes to our
consolidated financial statements located in Part I, Item 1, "Financial
Statements (unaudited)", of this Quarterly Report. The Company has benefited
from various, now expired, stimulus measures made available to it through the
CARES Act enacted by Congress in response to the COVID-19 pandemic, which
allowed for, among other things: (i) a deferral of debt service payments on USDA
loans to maturity, (ii) an allowance for debt service payments to be made out of
replacement reserve accounts for HUD loans, and (iii) debt service payments to
be made by the SBA on all SBA loans.

In early 2020, the Company began on-going efforts to investigate alternatives to
retire or refinance our outstanding debt of Series A Preferred Stock through
privately negotiated transactions, open market repurchases, redemptions,
exchange offers, tender offers, or otherwise.  Costs associated with these
efforts have been expensed as incurred in "Other expense, net" and were $0.9
million and $0.2 million for the nine months ended September 30, 2021 and
September 30, 2020, respectively.

Debt Covenant Compliance

As of September 30, 2021, the Company was in compliance with the various financial and administrative covenants under the Company's outstanding credit related instruments.

Series A Preferred Dividend Suspension





On June 8, 2018, the Board indefinitely suspended quarterly dividend payments
with respect to the Series A Preferred Stock. As of September 30, 2021, as a
result of the suspension of the dividend payment on the Series A Preferred Stock
commencing with the fourth quarter 2017 dividend period, the Company has $34.6
million of undeclared preferred stock dividends in arrears. The Board believes
that the dividend suspension will provide the Company with additional funds to
meet, in part, its ongoing liquidity needs. As the Company has failed to pay
cash dividends on the outstanding Series A Preferred Stock in full for more than
four dividend periods, the annual dividend rate on the Series A Preferred Stock
for the fifth and future missed dividend periods has increased to 12.875%, which
is equivalent to $3.20 per share each year, commencing on the first day after
the missed fourth quarterly payment (October 1, 2018) and continuing until the
second consecutive dividend payment date following such time as the Company has
paid all accumulated and unpaid dividends on the Series A Preferred Stock in
full in cash.

Evaluation of the Company's Ability to Continue as a Going Concern





Under the accounting guidance related to the presentation of financial
statements, the Company is required to evaluate, on a quarterly basis, whether
or not the Company's current financial condition, including its sources of
liquidity at the date that the consolidated financial statements are issued,
will enable the Company to meet its obligations as they come due arising within
one year of the date of the issuance of the Company's consolidated financial
statements and to make a determination as to whether or not it is probable,
under the application of this accounting guidance, that the Company will be able
to continue as a going concern. The Company's consolidated financial statements
have been presented on a going concern basis, which contemplates the realization
of assets and the satisfaction of liabilities in the normal course of business.
In applying applicable accounting guidance, management considered the Company's
current financial condition and liquidity sources, including current funds
available, forecasted future cash flows, the Company's obligations due over the
next twelve months, and the Company's recurring business operating expenses.



The Company concludes that it is probable that the Company will be able to meet its obligations arising within one year of the date of issuance of these consolidated financial statements within the parameters set forth in the accounting guidance.





                                       42

--------------------------------------------------------------------------------

For additional information regarding the Company's liquidity, see Note 2 - Liquidity and Note 8 - Notes Payable and other debt, to the Company's consolidated financial statements located in Part I, Item 1, Notes to Consolidated Financial Statements", of this Quarterly Report.

Cash Flows

The following table presents selected data from our consolidated statements of cash flows for the periods presented:





                                                             Nine Months Ended September 30,
(Amounts in 000's)                                             2021                  2020

Net cash provided by operating activities - continuing operations

                                                $         4,307   

$ 1,933 Net cash used in operating activities - discontinued operations

                                                           (195 )              (1,017 )

Net cash used in investing activities - continuing operations

                                                           (119 )                (209 )

Net cash used in financing activities - continuing operations

                                                         (1,859 )                (999 )
Net change in cash and restricted cash                              2,134                  (292 )
Cash and restricted cash at beginning of period                     7,492                 8,038
Cash and restricted cash, ending                          $         9,626       $         7,746



Nine Months Ended September 30, 2021



Net cash provided by operating activities-continuing operations for the nine
months ended September 30, 2021 was approximately $4.3 million, primarily due to
changes in working capital, consisting of our collection of rent arrears from
the Wellington Lease Termination and income from operations less noncash charges
(primarily, depreciation and amortization and lease revenue in excess of cash
rent received). The $2.4 million increase compared to the same period in the
prior year includes $1.0 million Medicaid overpayment that the Company expects
to repay shortly and reflects the collection of $3.3 million from the Wellington
Lease Termination (excluding $0.2 million insurance refund), offset by payment
of $1.0 million of bed tax in arrears for the Powder Springs Facility, $0.1
million of other collection expenses, approximately $0.4 million additional
interest payments as result of the CARES ACT interest deferrals and additional
net operating outflows of $0.6 million.

Net cash used in operating activities-discontinued operations for the nine
months ended September 30, 2021 was approximately $0.2 million, excluding
non-cash proceeds and payments. This amount was to fund legal and associated
settlement costs related to our legacy professional and general liability claims
and expenses related to and payment of legacy accounts payable.

Net cash used in investing activities-continuing operations for the nine months
ended September 30, 2021 was approximately $0.1 million. This capital
expenditure was for computer hardware, software and furniture and fixtures for
the Tara Facility.

Net cash used in financing activities-continuing operations was approximately
$1.9 million for the nine months ended September 30, 2021. This is the result of
routine repayments totaling $1.0 million towards our senior debt obligations,
$0.1 million repayment of the City of Springfield, Ohio First Mortgage Revenue
Series 2012 B Bonds, and approximately $0.8 million toward our current insurance
funding of other debt for the Tara Facility and our directors and officers
insurance.

Nine Months Ended September 30, 2020



Net cash provided by operating activities-continuing operations for the nine
months ended September 30, 2020 was approximately $1.9 million, consisting
primarily of our income from operations less changes in working capital, and
noncash charges (primarily, depreciation and amortization, and lease revenue in
excess of cash rent). The Company received approximately a $0.4 million
principal payment from Peach upon modification of the Peach Line, $0.5 million
from rent arrears payment plans, and $0.2 million PPP loan proceeds, in addition
to net operating inflows of approximately $0.8 million.

Net cash used in operating activities-discontinued operations for the nine
months ended September 30, 2020 was approximately $1.0 million, excluding
non-cash proceeds and payments. This amount was to fund legal and associated
settlement costs related to our legacy professional and general liability claims
and payment of legacy accounts payable.

Net cash used in investing activities-continuing operations for the nine months ended September 30, 2020 was approximately $0.2 million. This capital expenditure was for a new sprinkler system at one of our leased properties.



Net cash used in financing activities-continuing operations was approximately
$1.0 million for the nine months ended September 30, 2020. This is the result of
routine repayments totaling approximately $1.2 million towards our debt
obligations, partially offset by receipt of $0.2 million proceeds from the PPP
Loan.

                                       43

--------------------------------------------------------------------------------

Notes Payable and Other Debt



For information regarding the Company's debt financings, see Note 8 - Notes
Payable and Other Debt, to the Company's Notes to our consolidated financial
statements located in Part I, Item 1, "Financial Statements (unaudited)", of
this Quarterly Report and Note 8 - Notes Payable and Other Debt to our audited
consolidated financial statements included in Part II, Item 8., "Financial
Statements and Supplementary Data" in the Annual Report.

Receivables

Our operations could be adversely affected if we experience further significant delays in receipt of rental income from our tenants.





As of September 30, 2021 and December 31, 2020, the Company reserved for
approximately $0.1 million and $1.4 million, respectively, of uncollected
receivables. Accounts receivable, net, totaled $1.9 million at September 30,
2021 and $2.1 million at December 31, 2020. For information regarding the
Company's Receivables, see Note 1 - Organization and Significant Accounting
Policies, to the Company's Notes to our consolidated financial statements
located in Part I, Item 1, "Financial Statements (unaudited)", of this Quarterly
Report.

Operating Leases



For information regarding the Company's operating leases, see Note 6 - Leases,
to the Company's Notes to consolidated financial statements located in Part I,
Item 1, "Financial Statements (unaudited)", of this Quarterly Report, and Note 6
- Leases located in Part II, Item 8, "Financial Statements and Supplementary
Data", included in the Annual Report.

Off-Balance Sheet Arrangements





Guarantee



On November 30, 2018, the Company subleased five facilities located in Ohio to
the Aspire Sublessees, formerly affiliated with MSTC Development Inc., pursuant
to the Aspire Subleases, whereby the Aspire Sublessees took possession of, and
commenced operating, the Aspire Facilities as subtenant. The Aspire Subleases
became effective on December 1, 2018 and are structured as triple net leases.
The Company agreed to indemnify Aspire against any and all liabilities imposed
on them as arising from the former operator, capped at $8.0 million. The Company
has assessed the fair value of the indemnity agreements as not material to the
financial statements at September 30, 2021.



For further information see Note 6 - Leases, to the Company's Notes to
consolidated financial statements located in Part I, Item 1, "Financial
Statements (unaudited)", of this Quarterly Report, and Note 6 - Leases located
in Part II, Item 8, "Financial Statements and Supplementary Data", included in
the Annual Report.



                                       44

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses